UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precision medicine in early breast cancer—beginning of a successful story?

ESMO open, 2023-02, Vol.8 (1), p.100780-100780, Article 100780

2023

Volltextzugriff (PDF)

Leiomyosarcoma of the lower rectum managed by radiotherapy and surgery: A case report and review of literature

Cancer radiothérapie, 2023-05, Vol.27 (3), p.235-239

2023

Volltextzugriff (PDF)

Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study

Annals of oncology, 2016-07, Vol.27 (7), p.1235-1241

2016

Volltextzugriff (PDF)

Iron homeostasis and anemia markers in early breast cancer

Clinica chimica acta, 2014-07, Vol.434, p.34-40

2014

Volltextzugriff (PDF)

Abstract P2-02-05: Persistence of PIK3CA mutations detection in cell free tumor DNA as surrogate markers for hormonosensibility in patients with hormone receptor-positive breast cancer. The miRho clinical study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-02-05

2018

Volltextzugriff (PDF)

285PGENOMIC PROFILE OF EARLY STAGE NODE-NEGATIVE LUMINAL BREAST CANCER ASSOCIATED WITH SHORT DISEASE-SPECIFIC SURVIVAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv95-iv95

2014

Volltextzugriff (PDF)

Mad2L1 Overexpression Leads to Early Metastasis in Breast Cancer

Annals of oncology, 2014-09, Vol.25, p.iv95

2014

Volltextzugriff (PDF)

Genomic Profile of Early Stage Node-Negative Luminal Breast Cancer Associated with Short Disease-Specific Survival

Annals of oncology, 2014-09, Vol.25, p.iv95

2014

Volltextzugriff (PDF)

283PMAD2L1 OVEREXPRESSION LEADS TO EARLY METASTASIS IN BREAST CANCER

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv95-iv95

2014

Volltextzugriff (PDF)

Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study††Presented in part at the 2013 and 2014 San Antonio Breast Cancer Symposiums

Annals of oncology, 2016-07, Vol.27 (7), p.1235-1241

2016

Volltextzugriff (PDF)

Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study super()

Annals of oncology, 2016-07, Vol.27 (7), p.1235-1241

2016

Volltextzugriff (PDF)

Eribex: a Retrospective, International, Multicenter Study on the Efficacy and Safety of Eribuline Mesylate in Metastatic Breast Cancer

Annals of oncology, 2014-09, Vol.25, p.iv129

2014

Volltextzugriff (PDF)

391PERIBEX: A RETROSPECTIVE, INTERNATIONAL, MULTICENTER STUDY ON THE EFFICACY AND SAFETY OF ERIBULINE MESYLATE IN METASTATIC BREAST CANCER

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv129-iv129

2014

Volltextzugriff (PDF)

Abstract P6-09-10: Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxy vitamin D levels in early breast cancer patients: A randomized phase III study

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P6-P6-09-10

2013

Volltextzugriff (PDF)

407 Stereotactic magnetic resonance-guided online adaptive radiotherapy in kidney oligometastases

Radiotherapy and oncology, 2024-08, Vol.197, p.S295-S296

2024

Volltextzugriff (PDF)

A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers

Clinical genetics, 2015-02, Vol.87 (2), p.133-140

2015

Volltextzugriff (PDF)

BPS804 Anti‐Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial

Journal of bone and mineral research, 2017-07, Vol.32 (7), p.1496-1504

2017

Volltextzugriff (PDF)

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection

British journal of cancer, 2018-03, Vol.118 (5), p.679-697

2018

Volltextzugriff (PDF)

MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein

Matrix biology, 2011-03, Vol.30 (2), p.145-153

2011

Volltextzugriff (PDF)

Mobility in osteogenesis imperfecta: a multicenter North American study

Genetics in medicine, 2019-10, Vol.21 (10), p.2311-2318

2019

Volltextzugriff (PDF)

Clinical Development Strategies and Outcomes in First-in-Human Trials of Monoclonal Antibodies

Journal of clinical oncology, 2015-07, Vol.33 (19), p.2158-2165

2015

Volltextzugriff (PDF)

Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M

Osteoarthritis and cartilage, 2008-01, Vol.16 (1), p.98-104

2008

Volltextzugriff (PDF)

Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta

Genetics in medicine, 2016-06, Vol.18 (6), p.570-576

2016

Volltextzugriff (PDF)

5-Fluorouracil-associated severe hypertriglyceridaemia with positive rechallenge

BMJ case reports, 2023-12, Vol.16 (12), p.e254871

2023

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(51)
Dissertationen
(1)

Sprache

Englisch
(49)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(24)
Humans
(19)
Female
(16)
Adult
(11)
Osteogenesis Imperfecta
(10)
Middle Aged
(9)
Male
(8)
Oncology
(8)
Adolescent
(7)
Aged
(7)
Genetics & Heredity
(6)
Breast Cancer
(5)
Cancer
(5)
Child
(5)
Osteogenesis
(5)
Osteogenesis Imperfecta - Physiopathology
(5)
Young Adult
(5)
Adamts
(4)
Aggrecans - Metabolism
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Precision medicine in early breast cancer—beginning of a successful story?

Leiomyosarcoma of the lower rectum managed by radiotherapy and surgery: A case report and review of literature

Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study

Iron homeostasis and anemia markers in early breast cancer

Abstract P2-02-05: Persistence of PIK3CA mutations detection in cell free tumor DNA as surrogate markers for hormonosensibility in patients with hormone receptor-positive breast cancer. The miRho clinical study

285PGENOMIC PROFILE OF EARLY STAGE NODE-NEGATIVE LUMINAL BREAST CANCER ASSOCIATED WITH SHORT DISEASE-SPECIFIC SURVIVAL

Mad2L1 Overexpression Leads to Early Metastasis in Breast Cancer

Genomic Profile of Early Stage Node-Negative Luminal Breast Cancer Associated with Short Disease-Specific Survival

283PMAD2L1 OVEREXPRESSION LEADS TO EARLY METASTASIS IN BREAST CANCER

Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study††Presented in part at the 2013 and 2014 San Antonio Breast Cancer Symposiums

Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study super()

Eribex: a Retrospective, International, Multicenter Study on the Efficacy and Safety of Eribuline Mesylate in Metastatic Breast Cancer

391PERIBEX: A RETROSPECTIVE, INTERNATIONAL, MULTICENTER STUDY ON THE EFFICACY AND SAFETY OF ERIBULINE MESYLATE IN METASTATIC BREAST CANCER

Abstract P6-09-10: Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxy vitamin D levels in early breast cancer patients: A randomized phase III study

407 Stereotactic magnetic resonance-guided online adaptive radiotherapy in kidney oligometastases

A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers

BPS804 Anti‐Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection

MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein

Mobility in osteogenesis imperfecta: a multicenter North American study

Clinical Development Strategies and Outcomes in First-in-Human Trials of Monoclonal Antibodies

Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M

Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta

A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta

5-Fluorouracil-associated severe hypertriglyceridaemia with positive rechallenge

Suchergebnisse filtern